Artelo Biosciences, Inc. (ARTLW) NASDAQ
0.01
+0(+0.00%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.87M |
| Enterprise Value | 2.97M |
| P/E Ratio | -0.08 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 0 |
| Price/Book Ratio | 0.16 |
| Enterprise/Revenue | 0 |
| Enterprise/EBITDA | 0.48 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0 |
| Operating Margin | 0 |
Management Effectiveness
| Return On Assets | -1.08 |
| Return On Equity | -16.02 |
Income Statement
| Revenue | 0 |
| Revenue/Share | 0 |
| Gross Profit | 0 |
| EBITDA | -12.54M |
| Net Income | -12.88M |
| Diluted EPS | -5.47 |
Balance Sheet
| Total Cash | 10.27M |
| Total Cash/Share | 13.9 |
| Total Debt | 755,000 |
| Total Debt/Equity | 0.11 |
| Current Ratio | 1.79 |
| Book Value Per Share | 9.03 |
Price History
| 52-Week Change | -88.8 |
| 52-Week High | 0.01 |
| 52-Week Low | 0.01 |
| Moving Average 50 Days | 0 |
| Moving Average 200 Days | 0 |
Statistics
| Average Volume | 0 |
| Shares Outstanding | 2.33M |
| % Held by Institutions | 1.58 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
